Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arutha Kulasinghe

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Clinical & Translational Immunology|June 5, 2024
Characterisation of circulating tumor-associated and immune cells in patients with advanced-stage non-small cell lung cancerVahid Yaghoubi Naei, Ekaterina Ivanova, William Mullally, et al.
Therapeutic Advances in Medical Oncology|September 11, 2023
Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNAVahid Yaghoubi Naei, Pritam Bordhan, Fatemeh Mirakhorli, et al.
Translational Lung Cancer Research|November 19, 2020
<i>Ex vivo</i> culture of circulating tumour cells derived from non-small cell lung cancerJoanna Kapeleris, Arutha Kulasinghe, Majid Ebrahimi Warkiani, et al.
Pharmaceuticals (Basel, Switzerland)|September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2021
The Pandora's box of novel technologies that may revolutionize lung cancerHabib Sadeghi Rad, Hamid Sadeghi Rad, Yavar Shiravand, et al.
Oral Oncology|May 8, 2026
Tertiary lymphoid structures in head and neck squamous cell carcinoma as predictors of response to immunotherapyCara Griffin, Meg L Donovan, Clara Lawler, et al.
Cancer Medicine|December 20, 2018
The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancerArutha Kulasinghe, Joanna Kapeleris, Rebecca Kimberley, et al.
Trends in Biotechnology|March 21, 2022
Single-cell analysis of circulating tumour cells: enabling technologies and clinical applicationsPayar Radfar, Hamidreza Aboulkheyr Es, Rob Salomon, et al.
Clinical & Translational Immunology|July 19, 2024
Spatial proteomic profiling of tumor and stromal compartments in non-small-cell lung cancer identifies signatures associated with overall survivalVahid Yaghoubi Naei, James Monkman, Habib Sadeghirad, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung CancerQuan Zhou, Xueming Niu, Zhen Zhang, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Clinical & Translational Immunology|June 5, 2024
Characterisation of circulating tumor-associated and immune cells in patients with advanced-stage non-small cell lung cancerVahid Yaghoubi Naei, Ekaterina Ivanova, William Mullally, et al.
Therapeutic Advances in Medical Oncology|September 11, 2023
Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNAVahid Yaghoubi Naei, Pritam Bordhan, Fatemeh Mirakhorli, et al.
Translational Lung Cancer Research|November 19, 2020
<i>Ex vivo</i> culture of circulating tumour cells derived from non-small cell lung cancerJoanna Kapeleris, Arutha Kulasinghe, Majid Ebrahimi Warkiani, et al.
Pharmaceuticals (Basel, Switzerland)|September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2021
The Pandora's box of novel technologies that may revolutionize lung cancerHabib Sadeghi Rad, Hamid Sadeghi Rad, Yavar Shiravand, et al.
Oral Oncology|May 8, 2026
Tertiary lymphoid structures in head and neck squamous cell carcinoma as predictors of response to immunotherapyCara Griffin, Meg L Donovan, Clara Lawler, et al.
Cancer Medicine|December 20, 2018
The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancerArutha Kulasinghe, Joanna Kapeleris, Rebecca Kimberley, et al.
Trends in Biotechnology|March 21, 2022
Single-cell analysis of circulating tumour cells: enabling technologies and clinical applicationsPayar Radfar, Hamidreza Aboulkheyr Es, Rob Salomon, et al.
Clinical & Translational Immunology|July 19, 2024
Spatial proteomic profiling of tumor and stromal compartments in non-small-cell lung cancer identifies signatures associated with overall survivalVahid Yaghoubi Naei, James Monkman, Habib Sadeghirad, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung CancerQuan Zhou, Xueming Niu, Zhen Zhang, et al.
Pageof 11